Clinical trial Recruiting at 1 site Observational Ages 0 Days to 28 Days

Assessing Newborn Screening Using Genome Sequencing in France

Official title: A Pilot Study to Assess the Feasibility and Acceptability of Newborn Screening Using in Silico Panel-based Solo Genome Sequencing in France PERIGENOMED-CLINICS 1 (PGC1 Study)

Run by Centre Hospitalier Universitaire Dijon · NCT06875089 · Data updated 2026-11-12

This study is testing whether using genome sequencing for newborn screening in France can be accepted by parents and help identify rare diseases in babies.

Quick facts

Study typeObservational
Ages0 Days to 28 Days
SexAll
Enrollment5000 (estimated)
SponsorCentre Hospitalier Universitaire Dijon
Academic / other
Locations5 sites (Angers and 4 other locations)
StatusRecruiting
StartedMay 5, 2025
Main results expectedMay 2027
Study endsJuly 2032
Registry record updatedJune 17, 2026
Trial IDNCT06875089 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include parents or legal guardians of newborns born in participating maternity units who are open to conventional newborn screening.

Probably not a fit

Patients who may not benefit include those whose newborns are not born in the participating centers or who object to the use of their data.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot study evaluates the feasibility and acceptability of implementing newborn screening programs based on genome sequencing in France. It aims to gather data from parents and newborns in participating maternity units to understand the potential benefits and challenges of such screening. The study will involve qualitative and quantitative assessments, including satisfaction questionnaires and interviews with healthcare researchers. The goal is to explore how genome sequencing can be integrated into existing newborn screening practices for rare diseases.

Why it matters

Potential benefit: If successful, this study could enhance early detection and intervention for rare diseases in newborns, potentially improving health outcomes.

How similar studies have gone: While similar genome sequencing approaches have shown success in other countries, this specific implementation in France is novel and untested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

For satisfaction study about the information \& identification of determinants of acceptability :

Inclusion criteria for parents/legal guardians :

* All future parents approached for whom the unborn child will be cared for in the participating maternity unit
* At least one parent/legal guardian who received information about the study
* Future parents/legal guardian who do not object to the use of their data
* Parent(s) or legal guardian(s) affiliated to a social security system or beneficiaries of such a system

For pGS-NBS :

Inclusion criteria for newborn :

* All babies born in one of the participating centers or born by chance outside the maternity but whom care will be carried out in the participating center
* Newborn who are less than 28 days at the date of the collection of PGC1 blotting paper

Inclusion criteria for parents/legal guardians

* At least one biological parent who received information about the study
* Parent(s) or legal guardian(s) who do not object to "conventional" NBS
* At least one parent/legal guardian able to provide consent for testing the infant
* Informed consent signed by at least one parent/legal guardian
* Agreement of the second parent/legal guardian for testing the infant (unless he is unknown or loss of contact) obtained from the first parent/legal guardian if his written informed consent has not been obtained
* Parent(s) or legal guardian(s) affiliated to a social security system or beneficiaries of such a system

Exclusion Criteria:

Non inclusion criteria for satisfaction studies and pGS-NBS :

Non-inclusion criteria for parents/legal guardians :

* Parent(s) or legal guardian(s) under legal protection (guardianship, tutorship) or to a court order Non-inclusion criteria for newborn
* Babies born under anonymous birth according to the French law, known as "nés sous X"

Where it's running

  • CHU Dijon Bourgogne
    Dijon, France
    Recruiting
  • CHU d'Angers
    Angers, France
    Not yet recruiting
  • CHU Besançon
    Besançon, France
    Not yet recruiting
  • CHU Hôtel Dieu
    Nantes, France
    Not yet recruiting
  • CHU Rennes - Hôpital Sud
    Rennes, France
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.